Komori
Remixpoint (3825) · InitiativeDropped

Revenue growth in the medical and welfare sectors of the Medical Business

First written in FY2024. 1 of 3 entries say "Advanced", first in FY2025-H1. Latest entry: FY2025.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024AdvancedFY2025-H12024: 220242025: 12025
Same theme, other companies
Strengthening Customer Acquisition through Enhanced Web Marketing and Sales CapabilitiesA theme 3 companies write about · 1 as a headwind · 3 as a tailwind

0 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025DroppedAnnual report

    「As of 30 May 2025, all shares held by the company had been sold, and the business was discontinued effective 12 June of the same year.」

    The policy presented in the previous fiscal year of expanding earnings in the fields of clinical medicine and dentistry, medical consulting and welfare was no longer an ongoing theme for the group following the sale of ゼロメディカル and the discontinuation of the medical business.
  2. FY2025-H1AdvancedAnnual report

    「The medical business comprises ゼロメディカル, which became a wholly owned subsidiary through a share exchange effective 1 December 2023, and operates a web creation business centered on selling web marketing tools specializing in medical institutions; a medical consulting business providing management support through management improvement consulting specializing in medical institutions, regenerative medicine marketing and media communications; and welfare-related businesses operating after-school day services, Type B continuous employment support facilities and home-visit care facilities. As a result, this segment recorded revenue of ¥654 million and segment profit (operating profit) of ¥105 million.」

    For the medical business after ゼロメディカル became a wholly owned subsidiary, the company presented its composition of web creation, medical consulting and welfare-related businesses and recorded revenue of ¥654 million and segment profit of ¥105 million in the current interim period.
  3. FY2024First statedAnnual report

    「Going forward, creating new revenue opportunities in medical fields such as clinical medicine and dentistry will be a challenge in order to further expand earnings. To this end, we will actively consider new businesses by leveraging our existing transaction network, including our existing customers.」

    Following ゼロメディカル becoming a wholly owned subsidiary, the company first explicitly stated its policy of pursuing new businesses and revenue opportunities by leveraging its existing network, based on website development and management support for medical and dental providers, regenerative medicine marketing and welfare-related businesses.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Remixpoint yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Revenue growth in the medical and welfare sectors of the Medical Business | Remixpoint,inc. (3825) | Komori